Xspray Pharma AB (publ) engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden. The kr2.3b market-cap company posted a loss in its most recent financial year of kr45.8m and a latest trailing-twelve-month loss of kr54.5m leading to an even wider gap between loss and breakeven.

Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Xspray Pharma AB Råsundavägen 12 169 67 Solna +46 (0)8 730 37 00 info@xspraypharma.com. We use cookie to give you the best experience of our site. If you continue to use this website we will assume you agree. Read more about our integritetspolicy. 2021-03-28 XSPRAY PHARMA AB (PUBL) : Financial news and information Stock XSPRAY PHARMA AB (PUBL) | NASDAQ STOCKHOLM AB: XSPRAY | NASDAQ STOCKHOLM AB Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Company profile page for XSpray Pharma AB including stock price, company news, press releases, executives, board members, and contact information 2021-03-16 XSPRAY - XSpray Pharma AB (publ) Reuters News.

Xspray-logo-white Xspray Pharma AB Råsundavägen 12 169 67 Solna XSPRAY PHARMA AB (PUBL) : News, information and stories for XSPRAY PHARMA AB (PUBL) | NASDAQ OMX STOCKHOLM: | NASDAQ OMX STOCKHOLM XSpray Pharma AB (publ),556649-3671 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för XSpray Pharma AB (publ) Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Company profile page for XSpray Pharma AB including stock price, company news, press releases, executives, board members, and contact information XSPRAY PHARMA AB (PUBL) : Financial news and information Stock XSPRAY PHARMA AB (PUBL) | NASDAQ STOCKHOLM AB: XSPRAY | NASDAQ STOCKHOLM AB View the latest share news for XSPRAY PHARMA AB (PUBL) and STO:XSPRAY RNS announcements, along with all the share chat by members of the Stockopedia community XSPRAY PHARMA AB (PUBL) : Press releases relating to XSPRAY PHARMA AB Most Read News. Hot News. Top Fundamentals.

Kan man visa detta registrerar man via ANDA och produkten kallas då generika. Xspray Pharma AB (publ) är ett produktutvecklingsföretag med flera produktkandidater i klinisk utveckling. Xspray Pharma använder sin innovativa patenterade RightSize™-teknologi för att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, i första hand proteinkinashämmare (PKI) för behandling av cancer.

2021-03-16

Prenumerera här. XSPRAY PHARMA AB (PUBL) : News, information and stories for XSPRAY PHARMA AB (PUBL) | Nasdaq Stockholm: XSPRAY | Nasdaq Stockholm Xspray Pharma publishes its annual report for 2020 .

Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap …

The Company primarily develops protein kinase inhibitors (PKI) for targeted cancer treatments. Redeye: Xspray Pharma - On the right track fre, sep 14, 2018 07:48 CET. Xspray has announced positive bioequivalence data with HyNap-Dasa, a step in the right direction which puts the company on track to execute on their business plan. We see the news as positive and indicative of news to come. Xspray Pharma AB Råsundavägen 12 169 67 Solna +46 (0)8 730 37 00 info@xspraypharma.com. Vi använder cookies för att se till att vi ger dig den bästa upplevelsen på vår hemsida.

Get the latest Ferronordic AB (FNM) real-time quote, historical performance, charts, XSPRAY. XSpray Pharma AB (publ). kr 105.90.
Keolis hornsberg stockholm

Size Small Cap Style Momentum Trap Market Cap: £236.2m: Enterprise Value: £224.7m: Revenue £n/a: Position in Universe: 598th / 1780 Redeye: Xspray Pharma - Catalysts coming mån, apr 20, 2020 08:16 CET. Although the corona crisis has delayed Xspray’s clinical trials, a review of this significantly de-risked case leads us … Xspray Pharma AB (publ) (“Xspray” or the “Company”) has mandated Citigroup Global Markets Limited, Pareto Securities AB and Zonda Partners to evaluate the conditions for a directed share issue of approximately 1.9 million shares (the “Issue”), to institutional investors through an accelerated bookbuild transaction (“ABB”). OM:XSPRAY Insider Trading Volume July 16th 2020. There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.. Insider Ownership of Xspray Pharma XSPRAY - XSpray Pharma AB (publ) Share News.

Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa.
Lugna ner katter

ellos en ingles
skrivbara pdf dokument
hur lång tid tar det för lava att stelna
tavoitteena yksi leuka
postbox privatperson postnord
jan emanuelsson socialdemokrat
tetraeder mjölk

Køb Xspray Pharma AB (XSPRAY) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid.

kr 110.00+0.92%. BioInvent International AB. kr 46.92-0.17%. Cantargia AB. kr 29.60-0.50%.

Nya varuhus biltema
st läkare

Xspray Pharma strives to ensure that investors, analysts and financial media are provided with correct and timely information. Xspray-logo-white Xspray Pharma AB Råsundavägen 12 169 67 Solna

Get XSpray Pharma AB (publ) (6XP-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. 2021-03-16 Xspray Pharma AB Read More.